GSK Launches Plus Reduced Generic Exposure Will Boost U.S. Sales Ahead, Says CEO Witty
This article was originally published in The Pink Sheet Daily
Executive Summary
Products currently pending at FDA include Cervarix vaccine, Rezonic anti-emetic, Lamictal XR for epilepsy and Duodart fixed-dose combo.